{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:21:23Z","timestamp":1776892883486,"version":"3.51.2"},"reference-count":23,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5387\/fms.59.102","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T02:13:51Z","timestamp":1391566431000},"page":"102-107","source":"Crossref","is-referenced-by-count":15,"title":["EFFICACY OF CYCLOSPORINE A FOR STEROID-RESISTANT SEVERE HENOCH-SCH^|^Ouml;NLEIN PURPURA NEPHRITIS"],"prefix":"10.5387","volume":"59","author":[{"given":"SHINICHIRO","family":"OHARA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIHIKO","family":"KAWASAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KYOHEI","family":"MIYAZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ATSUSHI","family":"ONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUICHI","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUHIDE","family":"SUYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MITSUAKI","family":"HOSOYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rai A, Nast C, Alder S. Henoch-Schonlein purpura nephritis. J Am Soc Nephrol, <b>10<\/b>: 2637-2644, 1999.","DOI":"10.1681\/ASN.V10122637"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roberti I, Reisman L, Churg J. Vasculitis in childhood. Pediatr Nephrol, <b>7<\/b>: 479-489, 1993.","DOI":"10.1007\/BF00857580"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stewart M, Savage JM, Bell B, McCord B. Long-term renal prognosis of Henoch-Schonlein purpura in an unselected childhood population. Eur J Pediatr, <b>147<\/b>: 113-115, 1988.","DOI":"10.1007\/BF00442205"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goldstein AR, White RHR, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet, <b>339<\/b>: 280-282, 1992.","DOI":"10.1016\/0140-6736(92)91341-5"},{"key":"5","unstructured":"5. Kawasaki Y, Suzuki J, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schonlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant, <b>19<\/b>: 858-864, 2004."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Hen&ouml;ch-Schoenlein nephritis in children. Pedatri Nephrol, <b>12<\/b>: 244-248, 1998.","DOI":"10.1007\/s004670050447"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman A. Treatment of Henoch-Schoenlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol, <b>21<\/b>: 128-133, 2001.","DOI":"10.1159\/000046235"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA, <b>259<\/b>: 2121-2125, 1998.","DOI":"10.1001\/jama.259.14.2123"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Someya T, Kaneko K, Fujinaga S, Ohtaki R, Hira M, Yamashiro Y. Cyclosporin A heavy proteinuria in a child with Henoch-Sch&ouml;nlein purpura nephritis. Pediatr Int, <b>46<\/b>: 111-113, 2004.","DOI":"10.1111\/j.1328-0867.2004.01842.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shin JI, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ. Cyclosporin A therapy for severe Henoch-Sch&ouml;nlein nephritis with nephritic syndrome. Pediatr Nephrol, <b>120<\/b>: 1093-1097, 2005.","DOI":"10.1007\/s00467-005-1864-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for treatment of severe Henoch-Sch&ouml;nlein glomerulonephritis. Pediatr Nephrol, <b>18<\/b>: 1138-1142, 2003.","DOI":"10.1007\/s00467-003-1245-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ronkaninen J, Ala-Houhala M, Huttunen N-P, Jahnukainen T, Koskimies O, Orm&auml;l&auml; T. Outcome of Henoch-Sch&ouml;nlein nephritis with nephritic-range proteinuria. Clin Nephrol, <b>60<\/b>: 80-84, 2003.","DOI":"10.5414\/CNP60080"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, Suzuki S, Suzuki H. Plasmapheresis therapy for rapidly progressive Henoch-Sch&ouml;nlein nephritis. Pediatr Nephrol, <b>19<\/b>: 920-923, 2004.","DOI":"10.1007\/s00467-004-1514-0"},{"key":"14","unstructured":"14. Houssiau FA, Vasconcelos C, D'Cruz D. Immunosuppressive therapy in lupus nephritis: the EuroLupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum, <b>46<\/b>: 2121-2131, 2002."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Luqmani RA, Palmer RG, Bacon PA. Azathioprine, cyclophosphamide and chlorambucil. Baillieres Clin Rheumatol, <b>4<\/b>: 595-619, 1990.","DOI":"10.1016\/S0950-3579(05)80009-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ginler EM, Dooley MA, Aranow. Mycophenolate mofetil or intravenous CPM for lupus nephritis. N Engl J Med, <b>353<\/b>: 2219-2228, 2005.","DOI":"10.1056\/NEJMoa043731"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fau C, Sandra MD, Gomez M. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. nature medicine, <b>14<\/b>: 931-938, 2008.","DOI":"10.1038\/nm.1857"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mathieson PW. Proteinuria and Immunity-An Overstated Relationship? N Engl J Med, 359; <b>23<\/b>: 2492-2496, 2008.","DOI":"10.1056\/NEJMcibr0806881"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephritic syndrome. Arch Intern Med, <b>91<\/b>: 666-670, 2006.","DOI":"10.1136\/adc.2005.080960"},{"key":"20","unstructured":"20. Jennette JC, Olson JL, Schwartz MM, Silva FG. Pathology of the Kidney. 6<sup>th<\/sup> ed. Lippincott Williams and Wilkins, Philadelphia, 1427-1439, 2007."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kawasaki Y, Suyama K, Hashimoto K, Hosoya M. Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis. Clin Rheumatol, <b>30<\/b>: 529-535, 2011.","DOI":"10.1007\/s10067-010-1572-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N. Risk factors for cyclosporine-induced tubulointerstial lesions in children with minimal change nephritic syndrome. Kidney Int, <b>61<\/b>: 1801-1805, 2002.","DOI":"10.1046\/j.1523-1755.2002.00303.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jee MP, Sung CW, Jae IS, Hyunee Y, Ki SP. Cyclosporin A therapy for Henoch-Schonlein nephritis with nephritic-range proteinuria. Pediatr Nephrol, <b>26<\/b>: 411-417, 2011.","DOI":"10.1007\/s00467-010-1723-7"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:48:29Z","timestamp":1648212509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/59\/2\/59_102\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.59.102","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}